Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

Delayed Quote. Delayed  - 09/23 10:00:00 pm
71.34 USD   +0.44%
09/17 EXPRESS SCRIPTS : Launches Inflammatory Conditions Care Value Progra..
09/17 EXPRESS SCRIPTS : Launches Diabetes Care Value Program℠, Guara..
09/17 EXPRESS SCRIPTS : to Present at an Upcoming Conference
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales104 099100 887101 752101 827104 506108 509
Operating income (EBITDA)6 6646 8037 0477 2727 5147 741
Operating profit (EBIT)6 2956 4336 6476 5326 6156 986
Pre-Tax Profit (EBT)3 030-----
Net income1 8452 0082 4762 9083 0863 237
P/E ratio31,232,124,615,614,112,5
EPS ( $ )2,252,643,564,585,065,72
Dividend per Share ( $ )------
Yield------
Reference price ( $ )70.2484.6787.4171.3471.3471.34
Announcement Date02/20/2014
09:48pm
02/23/2015
09:01pm
02/16/2016
09:09pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt11 95611 73512 40612 63510 8048 790
Finance------
Operating income (EBITDA)6 6646 8037 0477 2727 5147 741
Leverage
(Debt/EBITDA)
1,79x1,73x1,76x1,74x1,44x1,14x
Capital Expenditure423437296310361373
Book Value Per Share (BVPS)28,2 $27,6 $25,7 $25,8 $26,8 $28,4 $
Cash Flow per Share5,80 $5,99 $6,97 $7,98 $9,49 $11,2 $
Announcement Date02/20/2014
09:48pm
02/23/2015
09:01pm
02/16/2016
09:09pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 44 960 M$ -
Entreprise Value (EV) 57 595 M$ 55 764 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 15,6x 14,1x
Capitalization / Revenue 0,44x 0,43x
EV / Revenue 0,57x 0,53x
EV / EBITDA 7,92x 7,42x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 2,77x 2,66x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 6,41% 6,33%
operating Leverage (Delta EBIT / Delta Sales) - 0,48x
Net Margin (Net Profit / Revenue) 2,86% 2,95%
ROA (Net Profit / Asset) 6,80% 7,25%
ROE (Net Profit / Equities) 21,6% 23,2%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   0,30% 0,35%
Cash Flow / Sales 4,94% 5,72%
Capital Intensity (Assets / Sales) 0,42x 0,41x
Financial Leverage (Net Debt / EBITDA) 1,74x 1,44x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend